Human Microbiome Market
According to Intent Market Research, the Human Microbiome Market is expected to grow from USD 0.7 billion in 2023 at a CAGR of 26.9% to touch USD 4.0 billion by 2030. The Human Microbiome Market is dominated by key players such as Seres Therapeutics, Enterome Bioscience, Second Genome, Finch Therapeutics, Vedanta Biosciences, 4D Pharma, Evelo Biosciences, BiomX, Rebiotix (Part of Ferring Pharmaceuticals), Symbiotix Biotherapies, Synthetic Biologics, Metabiomics Corporation, OptiBiotix Health Plc, Yakult Honsha, DuPont (IFF Health)